Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Pilot Study to Assess the Antiviral Activity of GSK1349572 Containing Regimen in Antiretroviral Therapy (ART)-Experienced, HIV-1-infected Adult Subjects With Raltegravir Resistance

NCT00950859 is registered in ClinicalTrials.gov with ViiV Healthcare as lead sponsor.

NCT NCT00950859
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00950859 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Pilot Study to Assess the Antiviral Activity of GSK1349572 Containing Regimen in Antiretroviral Therapy (ART)-Experienced, HIV-1-infected Adult Subjects With Raltegravir Resistance
Lead sponsor
ViiV Healthcare
Phase
Phase 2
Overall status
Completed
Start date
August 31, 2009
Completion date
January 31, 2015
Enrollment
51 (actual)
Sites
26

Conditions

As the registry lists them; a condition with its own page is linked.

infection, human immunodeficiency virus